|
AMRX Amneal Pharmaceuticals Inc 1723128 |
| Balance Sheet |
|
Current Assets
|
1,587,806,000 |
|
Assets
|
3,501,445,000 |
|
Current Liabilities
|
1,129,771,000 |
|
Liabilities
|
3,610,957,000 |
|
Equity
|
-109,512,000 |
| Cash Flow Statement |
|
Operating Cash Flow
|
295,099,000 |
|
Investing Cash Flow
|
-62,996,000 |
| Market Analysis |
|
Price
|
8.91 |
|
BVPS
|
21.86 |
|
PB
|
0.40 |
|
PS
|
2.78 |
|
FCF
|
232,103,000 |
|
| Earnings |
|
| Jan |
Feb |
Mar |
|
|
2/28 |
-0.38 |
3/01 |
0.54 |
|
|
Find a discrepancy? The most accurate way to find company fundamental data is to view AMRX documents filed with the SEC.
AMRX Filings
Clear
